A great place to start is with stability. Fortis ( TSX:FTS) is a regulated utility known for its highly predictable earnings ...

H2O America's growth is fueled by new connections, strategic acquisitions like Quadvest, and consistent rate increases. Find ...

BCX's portfolio is 95% large caps, concentrated in energy, mining, and agriculture, with enhanced income via covered call ...

Online fashion and beauty platforms are trying to shed their discount-driven identity by adding a layer of luxury.

The most pervasive issue identified by experts is a portfolio construction failure. UAE investors, across income levels, tend ...

What if a steady, low-risk investment could quietly build a ₹1 crore corpus? That too, without the stress of market volatility? That’s the idea investors often link with the Public Provident Fund (PPF ...

A mystery drug has shown promise for Parkinson’s disease, improving the mobility and balance of mice with Parkinson’s-like symptoms. The drug works by boosting the brain’s waste disposal system to ...

First launched in October 2024, Ford’s “Power Promise” was designed to make it even easier for drivers to go electric. The program includes a free Level 2 home EV charger, plus Ford will cover the ...

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. as drugmakers and the FDA alike seek to crack down on the ...

Some U.S. consumers have been cashing in their tax refunds early this year for a fresh pair of sneakers. Needham & Company analyst Tom Nikic wrote in a new research note that his firm found that ...

The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...

If your medical practice or pharmacy compounds, prescribes, or dispenses semaglutide or tirzepatide, you may already be in the crosshairs of pharmaceutical giants Novo Nordisk and Eli Lilly.